Follow
Poorval Joshi
Poorval Joshi
Senior Scientist I
No verified email
Title
Cited by
Cited by
Year
Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly (ADP-ribose …
PM Joshi, SL Sutor, CJ Huntoon, LM Karnitz
Journal of Biological Chemistry 289 (13), 9247-9253, 2014
2072014
m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development
Immunity 52, 1-15, 2020
121*2020
SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
Y Liang, T Tebaldi, K Rejeski, P Joshi, G Stefani, A Taylor, Y Song, ...
Leukemia 32 (12), 2659-2671, 2018
732018
Genomically incorporated 5-fluorouracil that escapes UNG-initiated base excision repair blocks DNA replication and activates homologous recombination
AM Huehls, CJ Huntoon, PM Joshi, CA Baehr, JM Wagner, X Wang, ...
Molecular pharmacology 89 (1), 53-62, 2016
582016
How do messenger RNA splicing alterations drive myelodysplasia?
P Joshi, S Halene, O Abdel-Wahab
Blood, The Journal of the American Society of Hematology 129 (18), 2465-2470, 2017
362017
Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies
G Biancon, P Joshi, JT Zimmer, T Hunck, Y Gao, MD Lessard, ...
Molecular cell 82 (6), 1107-1122. e7, 2022
282022
Visualization of herpes simplex virus type 1 virions using fluorescent colors
L Etienne, P Joshi, L Dingle, E Huang, P Grzesik, PJ Desai
Journal of virological methods 241, 46-51, 2017
112017
Incorporation of the Kaposi’s sarcoma-associated herpesvirus capsid vertex-specific component (CVSC) into self-assembled capsids
P Grzesik, D MacMath, B Henson, S Prasad, P Joshi, PJ Desai
Virus research 236, 9-13, 2017
92017
Multi-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies
G Biancon, P Joshi, JT Zimmer, T Hunck, Y Gao, MD Lessard, ...
bioRxiv, 2021.04. 22.441020, 2021
32021
Mettl3 mediated m6A modification is essential in fetal hematopoiesis
Y Gao, R Vasic, T Tebaldi, Y Song, R Teng, P Joshi, G Viero, A Xiao, ...
Blood 132, 3825, 2018
32018
Deconvolution of in vivo protein-RNA contacts using fractionated eCLIP-seq
G Biancon, E Busarello, P Joshi, BJ Lesch, S Halene, T Tebaldi
STAR protocols 3 (4), 101823, 2022
12022
U2AF1 Mutations Enhance Stress Granule Response in Myeloid Malignancies
G Biancon, P Joshi, JT Zimmer, T Hunck, Y Gao, MD Lessard, ...
Blood 138 (Supplement 1), 321-321, 2021
2021
High-Resolution Binding Atlas of U2AF1 Mutants Uncovers New Complexity in Splicing Alterations and Kinetics in Myeloid Malignancies
Blood 136 (Supplement 1), 3-4, 2020
2020
U2AF1 Driver Mutations in Hematopoietic Disorders Alter but Do Not Abrogate RNA Binding and Enlighten Structural Dependencies of the U2AF-RNA Complex
G Biancon, P Joshi, T Hunck, Y Gao, V Botti, A Qin, M Sadykov, X Wang, ...
Blood 134, 1230, 2019
2019
Loss of METTL3 Mediated m6A RNA Modification Results in Double-Stranded RNA Induced Innate Immune Response and Hematopoietic Failure
Y Gao, R Vasic, Y Song, R Teng, R Gbyli, G Biancon, R Nelakanti, E Kudo, ...
Blood 134, 450, 2019
2019
Abstract POSTER-BIOL-1325: Ovarian cancer-associated CDK12 mutations disable its kinase activity and cause defects in homologous recombination
PM Joshi, SL Sutor, CJ Huntoon, LM Karnitz
Clinical Cancer Research 21 (16_Supplement), POSTER-BIOL-1325-POSTER-BIOL-1325, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–16